Table 3.
Treatment by clinical paradigm
| By comorbidity | |
|---|---|
| Anxiety | Cognitive behavioral therapy, anxiolytics |
| POTS | Above maintenance fluids, supplemental NaCl, propranolol, exercise |
| Sleep deprivation | Sleep hygiene, melatonin 3–10 mg q.h. |
| Fatigue/limited stamina | Coenzyme Q10 10 mg/kg divided b.i.d. into 200–300 mg b.i.d. |
| – | |
| By subgroup | |
| Migraine-related | Antimigraine agents including triptans |
| Sato variant | Amitriptyline, short-acting ACE-inhibitors/β-blockers for acute hypertension |
| Mitochondrial dysfunction | Amitriptyline + coenzyme Q10 (± l-carnitine, riboflavin) |
| Catamenial | Low-estrogen birth control pills (90 day) or depo-medroxyprogesterone |
| By genotype | |
| RYR2 mutation | Propranolol |